Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-19-000067
Filing Date
2019-11-14
Accepted
2019-11-14 16:03:32
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10q2019q3.htm   iXBRL 10-Q 1735426
2 EXHIBIT 31.1 alpn-ex31120190930.htm EX-31.1 11831
3 EXHIBIT 31.2 alpn-ex31220190930.htm EX-31.2 11750
4 EXHIBIT 32.1 alpn-ex32120190930.htm EX-32.1 6585
5 EXHIBIT 32.2 alpn-ex32220190930.htm EX-32.2 6658
  Complete submission text file 0001626199-19-000067.txt   5648650

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20190930.xsd EX-101.SCH 38325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20190930_cal.xml EX-101.CAL 71286
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20190930_def.xml EX-101.DEF 134240
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20190930_lab.xml EX-101.LAB 491002
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20190930_pre.xml EX-101.PRE 267650
13 EXTRACTED XBRL INSTANCE DOCUMENT a10q2019q3_htm.xml XML 734774
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 191219932
SIC: 2834 Pharmaceutical Preparations